Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $9.87 | 52-week high | $16.59 |
| Prev. close | $10.04 | 52-week low | $9.87 |
| Day low | $9.87 | Volume | 300 |
| Day high | $9.87 | Avg. volume | 2,707 |
| 50-day MA | $11.59 | Dividend yield | N/A |
| 200-day MA | $13.60 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Range ETFs |
| Expense Ratio | 0.79% |
| Underlying Index | Range Cancer Therapeutics Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 7.70M |
| Net Asset Value (NAV) | $9.87 |
| Options? | Yes |
| Total Holdings | N/A |
CNCR Price Returns
| 1-mo | -13.30% |
| 3-mo | -19.82% |
| 6-mo | -32.99% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -43.18% |
| YTD | -19.82% |
| 2024 | -8.61% |
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.24% |
| 2020 | 36.53% |